Edwards Lifesciences (EW) PT Raised to $123 at Piper Jaffray
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
Go back to Edwards Lifesciences (EW) PT Raised to $123 at Piper Jaffray
April 27, 2016 12:44 PM EDT
Leerink Partners analyst Danielle Antalffy reiterated an Outperform rating and boosted is price target on Edwards Lifesciences (NYSE: EW) to $125.00 (from $115.00) following continued strong results.
Antalffy commented, "Last night, EW reported yet another quarter of better than-expected sales -- now its 8th consecutive quarter of sales outperformance -- with 1Q16 adjusted sales of $695.6M (+18% y/y, +19% ex. FX), coming in ~$27M ahead of us and over $30M ahead of the Street. Again, stronger... More
April 27, 2016 8:19 AM EDT
Jefferies analyst Raj Denhoy reiterated a Buy rating and raised his price target on Edwards Lifesciences (NYSE: EW) to $125.00 (from $105.00) following strong results and outlook.
Denhoy commented, "EW delivered another exceptionally strong quarter. US TAVR sales were up a remarkable 64%and this was before the... More
April 26, 2016 4:21 PM EDT
Edwards Lifesciences (NYSE: EW) reported Q1 EPS of $0.71, $0.05 better than the analyst estimate of $0.66. Revenue for the quarter came in at $697.3 million versus the consensus estimate of $664.95 million.
"We are very pleased to report a strong start to 2016," said Michael A. Mussallem, chairman and CEO.... More
